Aledade: $3.5B valuation, IPO Readiness 68, Series F. Value-based care company empowering independent primary care physicians to succeed in value-based contracts. Track live on The IPO Stack.
Value-based care company empowering independent primary care physicians to succeed in value-based contracts.
Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.
Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.
Track Aledade IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
Aledade has not announced a specific IPO date as of 2026. Track TechStackIPO for the latest funding milestones and IPO signals. Subscribe to The IPO Stack newsletter for weekly updates.
Aledade is valued at $3.5B as of June 2022. This valuation is based on its most recent private funding round tracked by TechStackIPO.
Accredited investors can access Aledade shares through secondary market platforms, pre-IPO investment funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace tracks available access options. Note: pre-IPO investments carry higher risk and limited liquidity compared to public market investing.
Aledade scores 68/100 (Grade: C) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.
Aledade has raised $660M in total venture capital and private equity funding, with backing from OMERS Growth Equity, General Atlantic, Meritech Capital.
Aledade's notable investors include OMERS Growth Equity, General Atlantic, Meritech Capital, Venrock, GV. Full investor details, funding round history, and lead investor breakdowns are available on TechStackIPO.
Aledade is a Healthcare Technology company. Value-based care company empowering independent primary care physicians to succeed in value-based contracts.